- Dec 27, 2023
Bone marrow transplant increases risk of cardiovascular disease and developing insulin resistance
In a collaborative study between Fred Hutchinson Cancer Center and the University of Minnesota, Dr. Baker along with Dr. Tyler Ketterl,...
- Dec 22, 2023
Unraveling predisposition in bilateral Wilms tumor
Children with bilateral Wilms tumor have a tumor in each of their kidneys — a condition that strongly suggests an underlying genetic or...
- Dec 21, 2023
Rethinking the Development of CAR T-Cell Products for Pediatric Cancer
In a commentary published in the Journal of Clinical Oncology, Claudia Rossig, MD, of the department of pediatric hematology and oncology...
- Dec 20, 2023
How research helped lead to FDA approval of a pediatric neuroblastoma drug
The drug, called eflornithine (DFMO) and newly branded as IWILFIN by US WorldMeds, reduces the risk of relapse for pediatric high-risk...
- Dec 19, 2023
Prediabetes treatment may reduce heart and kidney risks in childhood cancer survivors
Childhood cancer survivors have a higher prevalence of prediabetes and diabetes, which increases their risk of serious disease but also...
- Dec 19, 2023
'Tough kid': Borden boy to be featured in charity calendar to raise money for childhood cancer programs
A boy from CFB Borden is among a dozen kids who will be appearing in a charity calendar that will help raise funding and awareness about...
- Dec 18, 2023
Dabrafenib and trametinib – a new treatment on the horizon?
Recent research suggests that there could be a new treatment on the horizon for some children diagnosed with low and high-grade gliomas....
- Dec 17, 2023
Nivolumab Associated With Higher Survival in Pediatric Advanced-Stage Hodgkin Lymphoma
Replacing brentuximab vedotin with nivolumab in first-line treatment combined with the chemotherapy regimen AVD improved progression-free...